Wockhardt on Wednesday reported a net loss of Rs 16 crore in Q2FY25 led by improved performance across UK, India and emerging markets.
The Mumbai-based drug maker reported a net loss of Rs 73 crore in Q2FY24.
Revenue rose 7% year-on-year (y-o-y) to Rs.818 crore in Q2FY25 compared to Rs.762 crore in Q2FY24.
Shares of Wockhardt rose 0.73% to close at Rs 1190.15 on BSE, while the benchmark Sensex declined 1.25% to end at 77,690.95 points on Wednesday.
The EBITDA for the quarter is Rs.139 crore registering a growth of 71% y-o-y, while the EBITDA margins improved 630 basis points to 17%.
Stock Trading
Options Scalping Made Easy
By — Sivakumar Jayachandran, Ace Scalper
Stock Trading
Options Trading Course For Beginners
By — Chetan Panchamia, Options Trader
Stock Trading
Derivative Analytics Made Easy
By — Vivek Bajaj, Co Founder- Stockedge and Elearnmarkets
Stock Trading
Point & Figure Chart Mastery: A Comprehensive Trading Guide
By — Mukta Dhamankar, Full Time Trader, 15 Years Experience, Instructor
Stock Trading
Technical Analysis Made Easy: Online Certification Course
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
Macroeconomics Made Easy: Online Certification Course
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Stock Trading
Introduction to Technical Analysis & Candlestick Theory
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
ROC Made Easy: Master Course for ROC Stock Indicator
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Sto